DNM2 Gene Centronuclear Myopathy Type 1 Genetic Test
Centronuclear myopathy type 1 is a rare genetic disorder that affects muscle function. DNA Labs UAE offers a comprehensive genetic test for this condition.
Test Name: DNM2 Gene Centronuclear Myopathy Type 1 Genetic Test
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the DNM2 Gene Centronuclear Myopathy Type 1 Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected with DNM2 Gene Centronuclear Myopathy Type 1.
Test Details
The DNM2 gene is associated with centronuclear myopathy type 1. This genetic test uses NGS technology to analyze the patient’s DNA and identify any changes or mutations in the DNM2 gene. The results of this test can help diagnose centronuclear myopathy type 1 and guide treatment options. Additionally, it can identify carriers of the gene mutation and provide valuable information for family planning decisions.
Test Name | DNM2 Gene Centronuclear myopathy type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DNM2 Gene Centronuclear myopathy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DNM2 Gene Centronuclear myopathy type 1 |
Test Details |
The DNM2 gene is associated with centronuclear myopathy type 1, a rare genetic disorder that affects muscle function. NGS genetic testing can identify mutations in the DNM2 gene that can cause this condition. This test involves analyzing the patient’s DNA to identify any changes or mutations in the DNM2 gene. The results of this test can help diagnose centronuclear myopathy type 1 and guide treatment options. It can also help identify carriers of the gene mutation and inform family planning decisions. |